AVANOS MEDICAL, INC. (NYSE:AVNS - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $11.50 and last traded at $11.59, with a volume of 128089 shares. The stock had previously closed at $11.86.
AVANOS MEDICAL Trading Down 3.4%
The company has a debt-to-equity ratio of 0.12, a current ratio of 2.57 and a quick ratio of 1.56. The company's fifty day moving average is $12.32 and its 200-day moving average is $13.87. The stock has a market cap of $520.20 million, a PE ratio of -1.34 and a beta of 1.12.
AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a negative net margin of 55.80% and a positive return on equity of 6.26%. The company had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. During the same quarter in the previous year, the company earned $0.22 earnings per share. The firm's revenue for the quarter was up .8% on a year-over-year basis. On average, analysts predict that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AVNS. Quantbot Technologies LP purchased a new position in AVANOS MEDICAL in the fourth quarter valued at $64,000. State of Wyoming increased its holdings in AVANOS MEDICAL by 132.0% in the fourth quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after buying an additional 2,923 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in AVANOS MEDICAL by 493.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after buying an additional 6,714 shares in the last quarter. Heritage Family Offices LLP purchased a new position in AVANOS MEDICAL in the first quarter valued at $146,000. Finally, EP Wealth Advisors LLC increased its holdings in AVANOS MEDICAL by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock valued at $161,000 after buying an additional 1,289 shares in the last quarter. Hedge funds and other institutional investors own 95.17% of the company's stock.
AVANOS MEDICAL Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
